China Shineway Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
China Shineway Pharmaceutical Group has a total shareholder equity of CN¥7.0B and total debt of CN¥300.0M, which brings its debt-to-equity ratio to 4.3%. Its total assets and total liabilities are CN¥9.6B and CN¥2.5B respectively. China Shineway Pharmaceutical Group's EBIT is CN¥970.1M making its interest coverage ratio -9.4. It has cash and short-term investments of CN¥5.9B.
Key information
4.3%
Debt to equity ratio
CN¥300.00m
Debt
| Interest coverage ratio | -9.4x |
| Cash | CN¥5.91b |
| Equity | CN¥7.03b |
| Total liabilities | CN¥2.54b |
| Total assets | CN¥9.57b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2877's short term assets (CN¥8.2B) exceed its short term liabilities (CN¥2.4B).
Long Term Liabilities: 2877's short term assets (CN¥8.2B) exceed its long term liabilities (CN¥105.5M).
Debt to Equity History and Analysis
Debt Level: 2877 has more cash than its total debt.
Reducing Debt: 2877's debt to equity ratio has increased from 0% to 4.3% over the past 5 years.
Debt Coverage: 2877's debt is well covered by operating cash flow (327.4%).
Interest Coverage: 2877 earns more interest than it pays, so coverage of interest payments is not a concern.